Business Wire - Research and Markets: Celebrex Will Remain the Market Leading Brand for Osteoarthritis Treatment until Patent Expiry in 2014, When More Than 70% First Year…
Monday, November 3rd, 2008 DUBLIN, Ireland — Research and Markets (http://www.researchandmarkets.com/research/0d0629/forecast_insight) has announced the addition of the “Forecast Insight: Osteoarthritis” report to their offering.
Introduction
With several recent non-approvable decisions in the osteoarthritis market since 2006, We have updated its forecast to account for the effect on the market. We have revised the marke…
